Elizabeth Crompton

C. Kyle Musgrove

John C. Phillips, Jr.

David A. Bilson

Scott Cunning

Huong Hguyen

Huong Nguyen

Amy K. Wigmore

Andrew J. Danford

Kevin M. Yurkerwich

Tracey C. Allen

Brian E. Farnan

Gregory H. Lantier

Michael J. Farnan

Jeffrey T. Hantson

Timothy A. Cook

Heather M. Petruzzi

Generic Eliquis® challenge sparks Pfizer/BMS lawsuit over an apixaban formulation patent requiring particle sizes with a "D90 equal to or less than about 89 µm."

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Name	Ratings
Bristol-Myers Squibb Co	L4 A
Pfizer Inc	L5 A

Name	Ratings
Wilmer Cutler Pickering Hale Dorr LLP	L5 A
Amy K. Wigmore	L4 E
Gregory H. Lantier	L3 A
Tracey C. Allen	L2 B
Andrew J. Danford	L1 D
Heather M. Petruzzi	L1 E
Kevin M. Yurkerwich	-- -- --
Jeffrey T. Hantson	-- -- --
Timothy A. Cook	-- -- --
Farnan LLPLocal	L4 E
Brian E. Farnan	L5 E
Michael J. Farnan	L5 E

Name	Ratings
Haynes & Boone LLP	L3 D
C. Kyle Musgrove	L4 E
Scott Cunning	L2 E
Huong Hguyen	-- -- --
Phillips Goldman McLaughlin & Hall PALocal	L3 E
John C. Phillips, Jr.	L5 E
David A. Bilson	L5 E
Parker Poe Adams & Bernstein LLP	L2 D
Elizabeth Crompton	L3 E
Attorney at Law	-- -- --
Huong Nguyen	-- -- --

1:17-cv-00375

Bristol Myers Squibb Co v. Breckenridge Pharmaceutical Inc